![]() ![]() These services will include research, development, and commercialization of new oncology therapeutics using genomics, including for identifying cancer mutations.’įeatured image: Acutis Diagnostics CEO Jibreel Srij expects gene sequencing to improve how cancer medication is developed and to allow for more targeted treatments. The company plans to provide specialized contract services to assist other biopharmaceutical companies through Acutis Biosciences. “Simply, we demand more of ourselves and each other to serve those who have entrusted us with their important care as best as we can.” Salaries posted anonymously by Acutis Diagnostics employees in Hicksville, NY. “We stress the importance of moving together with continuous improvement in mind,” says Javon Barnwell, vice president of human resources. 38 salaries for 24 jobs at Acutis Diagnostics in Hicksville, NY. The company has performed 2.5 million COVID tests over the past two years.Īcutis provides advanced polymerase chain reaction-based (PCR) tests for infectious diseases that may be misdiagnosed with traditional testing, such as urinary tract infections. They kept me updated with the location of my covid test, and I received my results in under 24 hours Amazingly pleasant to communicate with. It was launched as a clinical diagnostic laboratory in a 1,000-square-foot start-up space in Farmingdale.Īcutis also offers molecular testing with a focus on infectious diseases, which enabled it to respond to the COVID-19 pandemic. The team was incredible Best communication and customer service Ive received by far. The company has a 40,000-square-foot facility in Hicksville with more than 200 professional employees. Acutis is a diagnostic company with a commitment to the best science, technology and practices, all set in motion by. “Acutis expects that gene sequencing will dramatically improve the way cancer medication is developed and that biomarker-specific treatment will be based on diagnostics, such as those being developed by Acutis,” says Acutis CEO Jibreel Sarij. It’s new advanced gene sequencing technologies were featured recently in a Long Island Press article. iSpecimen Adds Acutis Diagnostics to Marketplace Platform to Support Oncology and Infectious Disease Research. The company says it is taking on urgent healthcare issues through the advancement of medical testing capabilities. Moreover, we are investing in the machine learning AI tools that will become increasingly important in the interpretation of the complex data sets that our multi-omics analyses will yield." Acutis Biosciences has developed specialized contract research services to enable biopharmaceutical companies to create value using a holistic approach to "next-generation multi-omics." The company is rolling out the first set of genomic offerings along with immunohistochemistry assays and building out integrated analytics across DNA, RNA, protein, and broader multi-omics.Acutis Diagnostics, a New York State laboratory, is developing advanced gene sequencing technologies that can be used in the clinic. Far too often, we have heard about the industry's dissatisfaction with CROs, whether it be slow turnaround time, incomplete data analytics, or missed opportunities to advance drug discovery with robust biomarker analytics. Acutis CEO Jibreel Sarij said, "We are reimagining biomarker discovery at the intersection of DNA, RNA, and protein diagnostics and are rewriting the rules to champion our biopharma partners. His extensive experience includes fostering strategic partnerships, implementing customer-focused programs, and growing complex businesses. ![]() Tremaine brings over 26 years of experience within the life sciences and CRO industry. In his new role, Tremaine will oversee commercial operations with an emphasis on collaboration and relentless dedication to clients' success. According to the company, this unique approach builds on the expertise gained through its standard-of-care business, Acutis Diagnostics, which has processed over three million patient samples over the past seven years with turnaround times that have been consistently at the top of the industry. Acutis Biosciences combines a multi-omics biomarker profiling approach with data integration to provide pharmaceutical and biotechnology companies with tools needed to help advance clinical discovery. The company also appointed Troy Tremaine as its Chief Commercial Officer. 06.21.23Īcutis Biosciences, a biomarker discovery provider, opened a state-of-the-art 60,000-square-foot facility in Monmouth Junction, NJ. Troy Tremaine brings more than 26 years of experience within the life sciences and CRO industry. 55 Reviews - Jobs 87 Salaries 3 Interviews 14 Benefits 6 Photos + Add a Review Acutis Diagnostics Jobs Hiring Post a Job Find Jobs Filter your search results by job function, title, or location. Acutis Biosciences Opens New Facility, Names New CCO ![]()
2 Comments
|
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |